These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7026249)

  • 61. Aprindine-induced agranulocytosis. Evidence for immunologic mechanism.
    Pisciotta AV; Cronkite C
    Arch Intern Med; 1983 Feb; 143(2):241-3. PubMed ID: 6401987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Moxaprindine in the acute treatment of ventricular arrhythmias in patients with cardiovascular disease.
    Staessen J; Kesteloot H
    Eur J Clin Pharmacol; 1981 Feb; 19(3):167-72. PubMed ID: 7215413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanism of aprindine induced agranulocytosis: direct toxicity on CFU-C and CFU-GEMM.
    Boogaerts MA; Peters M; Peersman C; Kesteloot H; Verwilghen RL
    Scand J Haematol; 1984 Feb; 32(2):175-8. PubMed ID: 6701462
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Oral antiarrhythmic longtime therapy with aprindine (AC 1802)].
    Breithardt G; Gleichmann U; Seipel L
    Verh Dtsch Ges Inn Med; 1973; 79():1001-3. PubMed ID: 4790079
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of intravenous sotalol, aprindine and the combination of sotalol and aprindine on chronic high frequency ventricular arrhythmias in man.
    Stroobandt R; Holvoet G; Verbeke N; Kesteloot H
    Eur Heart J; 1987 Apr; 8(4):372-7. PubMed ID: 2440683
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effects of intravenous administration of aprindine on electrophysiological parameters in patients with myocardial damage].
    Santinelli V; Chiariello M; Ferro G; Stanislao M; Condorelli M
    Boll Soc Ital Cardiol; 1979; 24(7):759-63. PubMed ID: 554662
    [No Abstract]   [Full Text] [Related]  

  • 67. Aprindine-induced liver injury.
    Elewaut A; Van Durme JP; Goethals L; Kauffman JM; Mussche M; Elinck W; Roels H; Bogaert M; Barbier F
    Acta Gastroenterol Belg; 1977; 40(5-6):236-43. PubMed ID: 920044
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical observations of the new anti-arrhythmic drug aprindine from long-term trend analyses(author's transl)].
    Freyland MD; Steffel D; Hilger HH
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1764-7. PubMed ID: 50917
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Aprindine (AC 1802), a new anti-arrhythmic drug.
    Kesteloot H; Van Mieghem W; De Geest H
    Acta Cardiol; 1973; 28(2):145-65. PubMed ID: 4121909
    [No Abstract]   [Full Text] [Related]  

  • 70. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM; Lavis A; Breekpot F
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pancytopenia under treatment with aprindine, a new anti-arrhythmic drug.
    Casteels-Van Daele M; Beirinckx J; De Cock P; Peeters M; Corbeel L
    Acta Paediatr Belg; 1977; 30(4):247-8. PubMed ID: 612124
    [No Abstract]   [Full Text] [Related]  

  • 72. [Aprindine in oral long-term preventive treatment of recurrent ventricular tachycardia (author's transl)].
    Frank R; Fournial JF; Vedel J; Fontaine G; Dragodanne C; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1977; 26(4):335-8. PubMed ID: 329737
    [No Abstract]   [Full Text] [Related]  

  • 73. A case of left atrial automatic tachycardia successfully treated with aprindine.
    Kuriyama M; Nagamoto Y; Nakata K; Hayakawa T; Kuroiwa A
    J UOEH; 1988 Dec; 10(4):417-22. PubMed ID: 3212299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.
    Van Durme JP; Bogaert MG; Rosseel MT
    Eur J Clin Pharmacol; 1974 Aug; 7(5):343-6. PubMed ID: 4607575
    [No Abstract]   [Full Text] [Related]  

  • 75. [Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].
    Hagemeijer F; Janse C; Hugenholtz PG
    Acta Cardiol; 1974; Suppl 18():409-21. PubMed ID: 4138502
    [No Abstract]   [Full Text] [Related]  

  • 76. Multiple drug toxicity. Overt and subtle signs in ventricular tachycardia.
    Vlay SC; Reid PR
    N Y State J Med; 1983; 83(11-12):1185-6. PubMed ID: 6580567
    [No Abstract]   [Full Text] [Related]  

  • 77. [Evaluation of the electrophysiological effects of aprindine in man, with particular regard to the ventricular preexcitation syndrome (author's transl)].
    Vergara G; Disertori M; Molinis G; Inama G; Antonini L; Del Favero A; Stefenelli C; Furlanello F
    G Ital Cardiol; 1979; 9(6):597-606. PubMed ID: 488596
    [No Abstract]   [Full Text] [Related]  

  • 78. [The therapeutic effect of aprindine in treating 9 cases of Wolff-Parkinson-White syndrome associated with auricular fibrillation (author's transl)].
    Wang HZ
    Zhonghua Nei Ke Za Zhi; 1982 Feb; 21(2):96-8. PubMed ID: 7094710
    [No Abstract]   [Full Text] [Related]  

  • 79. Agranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach.
    Ibáñez L; Juan J; Pérez E; Carné X; Laporte JR
    Eur Heart J; 1991 May; 12(5):639-41. PubMed ID: 1874265
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Drug information: agents for the treatment of arrhythmia. Therapeutic main group: Anti-arrhythmia agents. 11].
    Lumholtz IB
    Sygeplejersken; 1980 Nov; 80(44):19. PubMed ID: 6905455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.